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The purpose of this paper was to present morphological characteristics of potentially
malignant nodules revealed in a group of male smokers aged 50-74 with a very high
risk for developing lung cancer estimated in the study for lung cancer screening in
Cracow (Poland). Nine hundred male smokers aged 50 to 74 years were invited to
the study and were asked in questionnaires about e.g. smoking exposure history. Ex-
clusion criteria included e.g. positive cancer history and chest computed tomogra-
phy (CT) examination in the previous year. Based on CT results and characteristics
of pulmonary nodules subjects were classified to group A (low risk), group B (inde-
terminate) and group C (high-risk individuals – required work-up). Final diagnosis
was based on pathological results of postoperative material. Thirty-nine males of mean
age 63.4 (standard deviation (SD): 6.69 years) revealed 41 potentially malignant pul-
monary nodules in baseline screening. In 14 subjects 16 type C pulmonary nodules
were histologically proved. Nine nodules were found to be benign lesions, while
7 nodules revealed malignant lung cancer: 5 cases of adenocarcinoma and 2 cases
of adenosquamous carcinoma. We determined morphological characteristics of po-
tentially malignant pulmonary nodules in 39 high-risk male smokers and proved lung
cancer in 7 subjects.
Key words: lung cancer screening, pulmonary nodules, computer aided diagnosis,
adenocarcinoma, pulmonary nodule volumetry.
Introduction
Pulmonary nodules were common findings in lung
parenchyma especially in current and former smokers.
Improvement in detection of pulmonary nodules was pos-
sible by means of using spiral chest computed tomog-
raphy (CT) with postprocessing and computer aided di-
agnosis (CAD) systems [1-5]. There were many attempts
in lung cancer screening trials to provide evaluation of
solid pulmonary nodules, which could be considered as
potentially early stages of lung cancer [3, 5, 6]. How-
ever, most of the pulmonary nodules presented benign
diseases. Lung cancer is the leading cause of cancer deaths
in males, with a mean 5-year survival rate of about 10-
15%. Early detection and treatment of lung cancer played
an important role in improving treatment and decreas-
ing mortality. The best prognosis of about 70% 5-year
survival rate occurred in patients in stage I (T1N0M0).
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Aim of the study
The purpose of this paper was to present baseline
characteristics of potentially malignant nodules revealed
in a group of male smokers aged 50-74 with a very high
risk for developing lung cancer estimated in the
study for lung cancer screening in Cracow (Poland).
Material and methods
The study was approved by the Polish Ministry of
Science and Higher Education and by the ethics
board. All participants gave written informed consent.
The participants in the study in Cracow were invited
from the population registry and were asked in ques-
tionnaires about general health, alcohol consumption,
physical exercise, cancer history, family history of lung
cancer, body weight and height, level of education and
smoking exposure history (years smoked, cigarettes
smoked per day, years quit). Exclusion criteria included:
current or past renal cancer, melanoma or lung can-
cer diagnosed less than 5 years ago or lung cancer di-
agnosed 5 years or more ago but still under treatment,
obesity (BMI ≥ 30 kg/m2), NYHA III and IV, chest
CT examination in previous year. Additionally, 300 age-
matched control individuals were enrolled. In all par-
ticipants low-dose chest CT without contrast media in
spiral mode in inspiration was performed using 64 dual-
source CT with 0.75-mm slices in cranial-caudal scan
direction. KVp settings were dependent on body
weight, and mAs were adjusted by the machine. Dou-
ble reading of all images were performed with the Lung-
Care Siemens software package for multi-dimension-
al image processing and computer viewing. Pulmonary
nodule diameter and volume were automatically cal-
culated by means of a 3D (three dimensional) assess-
ment tool, which could be manually corrected by the
radiologist using 2D (two dimensional) measure-
ments.
According to NELSON criteria concerning size and
morphological features on baseline screening non-cal-
cified solid nodules were classified to three groups. Type
A nodules (negative test results) presented benign le-
sions with morphologically benign features (such as fat
or benign calcifications) and/or were smaller than
50 mm3. Type B nodules (indeterminate test results)
presented solid nodules of 50-500 mm3 in size. Final-
ly, type C nodules (positive test results, potentially ma-
lignant nodules) were larger than 500 mm3. Based on
CT examinations and characteristics of pulmonary nod-
ules, subjects were classified to group A, B or C. With-
in group A males revealed only type A pulmonary nod-
ules. Males were classified to group B or group C if any
pulmonary nodule of type B or type C respectively was
observed. Participants from group A with benign nod-
ules required an annual repeat scan. Subjects of group
B with indeterminate nodules required follow-up
scanning after 3-4 months to assess growth. Males of
group C were referred to further work-up and histo-
logical diagnosis.
There were 39 males who were classified to group
C with a very high risk of lung cancer. All subjects from
group C revealed potentially malignant nodules,
which required work-up and histological diagnosis. Of
the 39 participants with positive test results, 32 were
referred for workup, 3 were not referred (because of the
decision of pulmonologists), and 4 participants refused
further diagnostics. All 32 participants were diagnosed
by means of invasive procedures such as bronchoscopy
with EBUS-TBNA (endobronchial ultrasound – trans-
bronchial needle aspiration), in 7 cases PET CT was per-
formed, in 14 males surgical procedures by means of
minithoracotomy were performed. Based on intraop-
erative histopathological examinations, further decisions
about broadening the operation range were decided.
In case of a malignant nodule, lobectomy with lym-
phadenectomy was performed. Final diagnosis was based
on pathological results of postoperative material.
The analyses were based as the use of t test for nor-
mally distributed continuous variables, Mann-Whit-
ney U test, and χ2 test for categorical variables. The
prespecified significance level was set at α = 0.05. All
analyses were conducted using the statistical software
package STATISTICA v.10.
Results
Of the 39 participants of mean age 63.4 (standard
deviation (SD): 6.69 years) with positive test results,
33.3% (n = 13) were younger than 60 years old and
66.7% (n = 26) were ≥ 60 years old. 59% (n = 23)
were current smokers and 41% (n = 16) were former
smokers. 33.3% (n = 13) had positive family cancer
history. None of the respondents from group C revealed
exposure to asbestos longer than 10 years. Within 39
males with potentially malignant nodules 4 participants
refused further diagnostics, 32 (91.4% of 35 males) were
referred for workup, and 3 (8.6% of 35 males) were not
referred (because of the decision of pulmonologists).
33.3% (n = 13) of subjects revealed exertional cough,
25.6% (n = 10) permanent cough and 25.6% (n =
10) morning cough, and 17.9% (n = 7) spat sputum.
None of the participants revealed loss of weight, pneu-
monia or hemoptysis.
In 39 participants a total of 41 type C pulmonary
nodules of median volume 1197 mm3 (x
_
= 3843.8
mm3) were detected. Apart from potentially malignant
type C nodules also 156 type A nodules of median vol-
ume 17 mm3 (x
_
= 43.7 mm3) and 54 type B nodules
of median volume 99 mm3 (x
_
= 140.9 mm3) were ob-
served (Table I). According to location, potentially ma-
lignant pulmonary nodules (type C) were detected in
the right lung in 57.1% (n = 20) and in the upper lobes
in 51.4% (n = 18) (Table II).
MORPHOLOGICAL CHARACTERISTICS OF POTENTIALLY MALIGNANT PULMONARY NODULES IN HIGH-RISK MALE SMOKERS DETECTED
IN LUNG CANCER SCREENING TRIAL IN CRACOW, POLAND
116
All 32 participants were diagnosed by means of in-
vasive procedures such as bronchoscopy with EBUS-
TBNA (endobronchial ultrasound – transbronchial
needle aspiration), in 7 (21.9%) cases PET-CT was
performed and in 14 (43.6%) cases surgical procedures
by means of minithoracotomy were performed. In
56.3% (n = 18) of cases EBUS-TBNA revealed no
changes and in these subjects further control by
a pulmonologist was recommended. Based on
histopathological examination 9 types of benign lesions
in 7 participants were detected and included: 1 case of
hamartoma, seborrhoeic wart, hemorrhagic lesion, oblit-
erative bronchiolitis, nodular goiter, tubular bronchial
gland adenoma and hyperplastic bronchial polyp, and
2 cases of silicosis. Lung cancer was diagnosed by means
of invasive procedures in 7 (21.9%) of the 32 partici-
pants with 7 potentially malignant pulmonary nodules.
Within 5 males adenocarcinoma type was proved in 5
potentially malignant pulmonary nodules: 1 case pre-
sented papillary adenocarcinoma, 1 case acinar adeno-
carcinoma and 3 cases belonged to solid [NOS (not oth-
erwise specified)] type of adenocarcinoma. In 2 males with
2 type C pulmonary nodules adenosquamous carcino-
mas were histologically proved (Table III). Six out of 7
cases (85.7%) were classified as pathological stage I, 1
case out of 7 (14.3%) presented pathological stage IV.
Specificity for the baseline screening protocol was
96.4%. Sensitivity in baseline screening was not ob-
tained, because the study was still in the follow-up
phase. There was no significant difference in mean age
among males with lung cancer and without lung can-
cer. There was also no significant difference in years of
smoking duration, number of cigarettes smoked per
day, pack-years and number of pulmonary nodules
among men with lung cancer and without lung can-
cer. There was no significant correlation between pos-
itive family cancer history, current smoking, exposure
to asbestos and prevalence of lung cancer. However,
these results could be due to the very small number of
studied participants.
Discussion
Since the National Lung Screening Trial (NLST)
proved a 20.1% reduction in lung cancer mortality rate
in participants screened by low dose chest CT in com-
parison to chest radiograph, low dose CT (LDCT) be-
came a major technique used in lung cancer screening
studies [8]. Moreover, computer aided diagnosis (CAD)
systems in chest CT improved accuracy in detecting pul-
monary nodules considered as potentially early stages
of lung cancer [2, 3, 5, 7]. Detecting lung cancer at an
early stage improved treatment and the survival rate.
The aim of lung cancer screening trials still remained
detection of pulmonary nodules and distinguishing be-
nign from malignant ones based on their morpholog-
ical characteristics, to decrease the lung cancer mortality
rate on one hand and diminish over-diagnosis and un-
Table I. Volumetry categorized by type of pulmonary nodules within group C participants. AC, BC and CC – total
number of A, B and C nodules within group C subjects
TYPE OF PULMONARY NODULE GROUP C P
AC BC CC
Total number 156 54 41
Summary volumetry of pulmonary nodules [cm3] 6.8 7.6 157.6 < 0.001
Mean volumetry of single pulmonary nodule [mm3] 43.7 140.9 3843.8
Median [mm3] 17 99 1197
Table II. Structure of males based on location of pul-
monary nodules
LUNG N = 35
N %
Right 20 57.1
Left 13 37.1
Both 2 5.7
LOBE (SEGMENTS) N = 35
N %
Upper (1-3) 18 51.4
Lower (6-10) 13 37.1
Middle and uvula (4-5) 3 8.6
Upper and lower 1 8.3
Table III. Histopathological type of lung cancer detect-
ed in 7 subjects
HISTOPATHOLOGICAL TYPE N = 7
OF LUNG CANCER N %
Adenosquamous carcinoma 2 28.6
Adenocarcinoma: 5 71.4
Papillary type of adenocarcinoma 1 14.3
Acinar type of adenocarcinoma 1 14.3
Solid (NOS) type of adenocarcinoma 3 42.8
KINGA KISZKA, LUCYNA RUDNICKA-SOSIN, ROMANA TOMASZEWSKA, ET AL.
117
T
ab
le
IV
.H
is
to
pa
th
ol
og
ic
al
ty
pe
of
lu
ng
ca
nc
er
s
de
te
ct
ed
in
ba
se
lin
e
sc
re
en
in
g
in
lu
ng
ca
nc
er
sc
re
en
in
g
tr
ia
ls
N
O
.
N
U
M
B
ER
O
F
N
U
M
B
ER
O
F
T
U
M
O
U
R
H
IS
T
O
P
A
T
H
O
LO
G
IC
A
L
T
Y
P
E
O
F
LU
N
G
C
A
N
C
ER
S
A
U
T
H
O
R
S
A
N
D
Y
EA
R
T
R
IA
L
SC
R
EE
N
ED
D
IA
G
N
O
SE
D
D
IA
M
ET
ER
N
SC
LC
SU
B
T
Y
P
ES
SC
LC
O
T
H
ER
T
Y
P
ES
P
A
R
T
IC
IP
A
N
T
S
LU
N
G
C
A
N
C
ER
(M
M
)
O
F
C
A
N
C
ER
S
(B
A
SE
LI
N
E
SC
R
EE
N
IN
G
)
1
26
30
9
27
0
≥
4.
0
13
1
B
A
C
13
7
ca
rc
in
oi
d
A
be
rl
e
et
al
.[
8]
20
11
N
LS
T
ad
en
oc
ar
ci
no
m
a
la
rg
e
ce
ll
ca
rc
in
om
a
sq
ua
m
ou
s
ce
ll
un
kn
ow
n
ca
rc
in
om
a
2
36
42
53
≥
10
.0
41
ad
en
oc
ar
ci
no
m
a
(1
2)
un
sp
ec
ifi
ed
da
ta
(1
2)
W
ils
on
et
al
.[
9]
20
08
PL
uS
S
3
16
11
14
>
19
.8
12
ad
en
oc
ar
ci
no
m
a
(8
)
–
va
ri
ou
s
ty
pe
s
So
bu
e
et
al
.[
10
]
20
02
–
sq
ua
m
ou
s
ce
ll
ca
rc
in
om
a
(1
)
so
lid
N
O
S
(3
)
4
15
20
26
>
15
20
ad
en
oc
ar
ci
no
m
a
4
la
rg
e
ce
ll
Sw
en
se
n
et
al
.
[1
1]
20
05
–
or
B
A
C
(1
8)
ca
rc
in
om
a
(2
)
sq
ua
m
ou
s
ce
ll
ca
rc
in
om
a
(2
)
5
14
06
21
≥
8.
0
18
no
sp
ec
ifi
ed
2
ca
rc
in
oi
d
(1
)
Lo
pe
z
Pe
gn
a
et
al
.[
12
]
20
09
IT
A
LU
N
G
6
10
35
12
>
18
.0
11
ad
en
oc
ar
ci
no
m
a
(1
0)
–
la
rg
e
ce
ll
Po
st
or
in
o
et
al
.[
13
]
20
03
–
sq
ua
m
ou
s
ce
ll
ca
rc
in
om
a
(1
)
ca
rc
in
om
a
(1
)
7
10
00
7
≥
11
.0
6
ad
en
oc
ar
ci
no
m
a
(5
)
1
H
en
sc
hk
e
et
al
.
[5
]
20
01
EL
C
A
P
sa
rc
om
at
oi
d
(p
le
om
or
ph
ic
)
ca
rc
in
om
a
(1
)
8
91
1
12
≥
10
.0
11
no
sp
ec
ifi
ed
1
B
as
ta
ri
ka
et
al
.
[1
4]
20
05
–
9
81
7
11
>
10
.0
10
ad
en
oc
ar
ci
no
m
a
(5
)
1
D
ie
de
ri
ch
et
al
.[
15
]
20
04
–
sq
ua
m
ou
s
ce
ll
ca
rc
in
om
a
(5
)
10
90
0
7
≥
16
.6
7
ad
en
oc
ar
ci
no
m
a
(5
):
–
K
is
zk
a
et
al
.2
01
3
–
pa
pi
lla
ry
ty
pe
(1
)
ac
in
ar
ty
pe
(1
)
so
lid
N
O
S
(3
)
ad
en
os
qu
am
ou
s
ce
ll
ca
rc
in
om
a
(2
)
MORPHOLOGICAL CHARACTERISTICS OF POTENTIALLY MALIGNANT PULMONARY NODULES IN HIGH-RISK MALE SMOKERS DETECTED
IN LUNG CANCER SCREENING TRIAL IN CRACOW, POLAND
118
T
ab
le
IV
.C
on
t.
N
O
.
N
U
M
B
ER
O
F
N
U
M
B
ER
O
F
T
U
M
O
U
R
H
IS
T
O
P
A
T
H
O
LO
G
IC
A
L
T
Y
P
E
O
F
LU
N
G
C
A
N
C
ER
S
A
U
T
H
O
R
S
A
N
D
Y
EA
R
T
R
IA
L
SC
R
EE
N
ED
D
IA
G
N
O
SE
D
D
IA
M
ET
ER
N
SC
LC
SU
B
T
Y
P
ES
SC
LC
O
T
H
ER
T
Y
P
ES
P
A
R
T
IC
IP
A
N
T
S
LU
N
G
C
A
N
C
ER
(M
M
)
O
F
C
A
N
C
ER
S
(B
A
SE
LI
N
E
SC
R
EE
N
IN
G
)
11
51
9
5
>
20
.0
0
8
ad
en
oc
ar
ci
no
m
a
N
ov
el
lo
et
al
.
[1
6]
20
05
–
or
B
A
C
(4
)
sq
ua
m
ou
s
ce
ll
ca
rc
in
om
a
(1
)
12
46
6
1
>
10
.0
1
ad
en
oc
ar
ci
no
m
a
C
al
lo
le
ta
l.
[1
7]
20
07
–
13
44
9
2
≥
10
.0
1
no
sp
ec
ifi
ed
M
ac
R
ed
m
on
d
et
al
.[
18
]
20
06
–
14
92
2
>
10
.0
1
sq
ua
m
ou
s
ce
ll
G
ar
g
et
al
.[
19
]
20
02
–
ca
rc
in
om
a
15
60
2
>
10
.0
1
ad
en
oc
ar
ci
no
m
a
ca
rc
in
oi
d
(1
)
Pi
co
zz
ie
ta
l.
[2
0]
20
05
–
16
79
15
20
9
(t
ot
al
)*
>
9.
8
14
8
ad
en
oc
ar
ci
no
m
a
10
-c
om
bi
ne
d
la
rg
e
ce
ll
H
or
ew
eg
et
al
.[
21
]
20
13
N
EL
SO
N
(1
07
)–
B
A
C
(1
1)
ty
pe
ca
rc
in
om
a
(1
7)
–
sq
ua
m
ou
s
ce
ll
la
rg
e
ce
ll
ca
rc
in
om
a
(3
4)
ne
ur
oe
nd
oc
ri
ne
ad
en
os
qu
am
ou
s
ca
rc
in
om
a
(4
)
ce
ll
ca
rc
in
om
a
(4
)
ca
rc
in
oi
d
(6
)
sa
cr
om
at
oi
d
no
hi
st
ol
og
ic
al
(p
le
om
or
ph
ic
)
di
ag
no
si
s
(1
3)
ca
rc
in
om
a
(1
)
N
SC
LC
-N
O
S
(2
)
N
LS
T
–
N
at
io
na
lL
un
g
Sc
re
en
in
g
T
ri
al
;P
Lu
SS
–
Pi
tts
bu
rg
Lu
ng
Ca
nc
er
Sc
re
en
in
g;
EL
CA
P
–
Ea
rl
y
Lu
ng
Ca
nc
er
A
cti
on
Pr
og
ra
m
;N
EL
SO
N
–
N
Ed
er
la
nd
sL
eu
ve
ns
Lo
ng
ka
nk
er
Sc
re
en
in
gs
O
nd
er
zo
ek
(N
EL
SO
N
-s
cr
een
in
g
tr
ia
l)
in
hi
gh
ri
sk
su
bj
ect
s;
N
O
S
–
no
to
th
er
w
ise
sp
eci
fie
d;
B
A
C
–
br
on
ch
io
al
ve
ol
ar
ca
rc
in
om
a;
N
SC
LC
–
no
n
sm
al
lc
ell
lu
ng
ca
rc
in
om
a
KINGA KISZKA, LUCYNA RUDNICKA-SOSIN, ROMANA TOMASZEWSKA, ET AL.
119
necessary invasive or surgical procedures on the other
hand [7-9]. However, it was always histopathological
examination which established the final diagnosis.
In this study we revealed solid pulmonary nodules
in 92% (n=831) of participants in baseline screening,
which was much higher than that reported in the lit-
erature (5-51%) [7-20]. We obtained specificity of
96.4% of baseline screening, which was similar to the
published experience (92-99.6%) [7-20]. Sensitivity re-
mains unknown, for our study is still ongoing. We
proved lung cancer nodules in 0.7% (n = 7) of sub-
jects (0.2-3.7% in other studies), potentially malignant
non-lung cancer nodules in 3.5% (n = 32) of cases
(1-49% reported in the literature) and benign nodules
in 95.6% (n = 861) of males, which was similar to the
other studies (77-100%) [22]. We classified all male
smokers to group A, B or C according to NELSON cri-
teria, which referred to nodule volumetry [3, 4]. Sim-
ilarly to other trials, an annual scan for small nodules
(ø ≤ 5 mm) was performed, due to their very low like-
lihood of malignancy [1, 5, 6]. The main differences
between the protocol and other trials occurred with-
in group B (indeterminate nodules), with larger cut-
off of diameter and volumetry in our study (8-10 mm,
50-500 mm3 in comparison with 5-8 mm; 35-135 mm3
in other trials) [22]. It was in order to avoid over-di-
agnosis and unnecessary surgical procedures of inde-
terminate nodules in potentially healthy male smok-
ers, rather with the focus on delaying the decision of
invasive diagnostics, unless nodule growth was proved
[1, 4, 5]. However, considering the low lung cancer de-
tection rate in the studied sample (0.7%), which re-
mained much lower than the prevalence of potential-
ly malignant nodules (4.3%), and considering the large
total number of nodules detected in male smokers
(92%) in studied participants in Cracow, the question
about changing (decreasing) the cut-off size of inde-
terminate nodules for the Polish population remained
open.
Based on sub-type of histological analyses, adeno-
carcinoma type (with papillary, acinar, and solid
[NOS] variants) and adenosquamous cell carcinoma
type within potentially malignant pulmonary nodules
in the studied sample of elderly male smokers in Cra-
cow were proved.
NSCLC (non-small cell lung carcinoma) is the most
often proved lung cancer type in the literature (Table
IV). Among this group adenocarcinoma with BAC (bron-
chioalveolar type) was detected in over half of cases. The
second most often detected lung cancer type was squa-
mous cell carcinoma. Small cell lung carcinomas (SCLC),
large cell carcinomas, and carcinoid were diagnosed in
several single cases (Table IV). In our study 85.7% of
cases were classified as pathological stage I and 14.3%
of cases presented pathological stage IV, in comparison
to 70.8% (stage IA) and 8.1% (IIIB + IV) reported in
Horeweg’s paper summarizing the long-term Dutch-Bel-
gian part of the NELSON study [21]. Our results, how-
ever, remained similar to other trials [8, 12, 13].
Benign lesions were also histologically proved and pre-
sented various types of benign diseases. Median volume
of malignant nodules in our study is slightly higher than
that reported in the literature, but it could also be caused
by a different cut-off of median diameter, which was
cleared above [3, 4, 7]. Further studies and follow-up
are needed to improve guidelines for management of pul-
monary nodules detected on CT scans [6].
Conclusions
We determined morphological characteristics of
a group with potentially malignant pulmonary nodules
in 39 high-risk male smokers selected from a studied pop-
ulation in Cracow (Poland). We estimated median vol-
ume for each type C pulmonary nodule and for each type
A and B pulmonary nodule within group C. The preva-
lence of location of type C nodules in the right lung and
in the upper lobe was observed. In 7 cases lung cancer
was histologically proved with 5 cases of adenocarcino-
ma type and 2 cases of adenosquamous carcinomas. In
7 subjects 9 nodules were found to be benign lesions.
The project was funded by the Ministry of Science and
Higher Education, 331/N-HOL UMCG/2008/09/0.
The authors declare that there were no study sponsors in-
volved in the study design.
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